Evidence map›Paper›PMID 39044924›Full record

ReviewJournal of medicine and life2024

The burden of antibiotic resistance of the main microorganisms causing infections in humans - review of the literature.

Alexandru-Paul Baciu, Carmen Baciu, Ginel Baciu, Gabriela Gurau

Abstract readReview
In one paragraph

Review in Journal of medicine and life, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Journal of microbiology and biotechnology · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alexandru-Paul BaciuMedLife Hyperclinic Nicolae Balcescu, Galati, Romania.
Carmen BaciuMedLife Hyperclinic Nicolae Balcescu, Galati, Romania.
Ginel BaciuSf. Ioan Emergency Clinical Hospital for Children, Galati, Romania.
Gabriela GurauSf. Ioan Emergency Clinical Hospital for Children, Galati, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the biggest threats to human well-being and public health is antibiotic resistance. If allowed to spread unchecked, it might become a major health risk and trigger another pandemic. This proves the need to develop antibiotic resistance-related global health solutions that take into consideration microdata from various global locations. Establishing positive social norms, guiding individual and group behavioral habits that support global human health, and ultimately raising public awareness of the need for such action could all have a positive impact. Antibiotic resistance is not just a growing clinical concern but also complicates therapy, making adherence to current guidelines for managing antibiotic resistance extremely difficult. Numerous genetic components have been connected to the development of resistance; some of these components have intricate paths of transfer between microorganisms. Beyond this, the subject of antibiotic resistance is becoming increasingly significant in medical microbiology as new mechanisms underpinning its development are identified. In addition to genetic factors, behaviors such as misdiagnosis, exposure to broad-spectrum antibiotics, and delayed diagnosis contribute to the development of resistance. However, advancements in bioinformatics and DNA sequencing technology have completely transformed the diagnostic sector, enabling real-time identification of the components and causes of antibiotic resistance. This information is crucial for developing effective control and prevention strategies to counter the threat.

Indexed as

Anti-Bacterial AgentsDrug Resistance, MicrobialBacteriaBacterial InfectionsDrug Resistance, BacterialHumansAnti-Bacterial Agentsantibiotic resistanceantibioticsAOM, acute otitis mediabeta-lactamasecarbapenemsCDC, Centers for Disease Control and PreventioncIAI, complicated intra-abdominal infectionCRE, carbapenem-resistant EnterobacteralescUTI, complicated urinary tract infectionESBL, extended-spectrum beta-lactamaseHib, Haemophilus influenzae type bLVRE, linezolid/vancomycin -resistant enterococciMBC, minimum bactericidal concentrationMBL, metallo-beta-lactamasesMDR, multidrug-resistantmethicillin-resistant Staphylococcus aureusMIC, minimum inhibitor concentrationMRSA, methicillin-resistant Staphylococcus aureusPBP, penicillin-binding proteinSCCmec staphylococcal chromosomal cassette mecvancomycinVRE, vancomycin-resistant enterococciXDR, extensively drug-resistant

Identifiers

PMID39044924
PMCPMC11262613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.